ImmuCell, Nutrition 21 deal

NXXI received a $1 million payment from ICCC in exchange for NXXI waiving its right to receive up to $300,000 in regulatory milestones and 3-5% royalties on sales of ICCC's Mast Out nisin-based treatm...